Humpa, Rena .
HRN: 23-85-03 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
AMPICILLIN 500MG (VIAL)
10/23/2023
10/24/2023
IV
2gm
Q6
Rupture BOW
Waiting Final Action
10/24/2023
CEFUROXIME 1.5GM (VIAL)
10/24/2023
10/25/2023
IV
1.5gm 3 Doses
Q8
S/P CS
Waiting Final Action